Innovations in prostate biopsy strategies for active surveillance and focal therapy

Current Opinion in Urology

Volumn 21, Issue 2, 2011, Pages 115-120

  Ukimura, Osamu ^a   Hung, Andrew J ^a   Gill, Inderbir S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Image fusion; navigation; prostate biopsy; robot; transrectal ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER THERAPY; FOCAL THERAPY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; DIAGNOSTIC IMAGING; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; PROSTATE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SENTINEL SURVEILLANCE;

EID: 79951675315     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283435118     Document Type: Article

References (50)

1. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis dueto prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94:981-990. (Pubitemid 34814727)
2. Master VA, Chi T, Simko JP, et al.The independentimpactofextended pattern biopsy on prostate cancer stage migration. J Urol 2005; 174:1789-1793. (Pubitemid 41546940)
3. Graif T, Loeb S, Roehl KA, et al. Under diagnosis and over diagnosis of prostate cancer. J Urol 2007; 178:88-92. (Pubitemid 46908727)
4. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352:1977-1984 (Pubitemid 40638368)
5. Klotz L. Active surveillance for prostate cancer:for whom? J Clin Oncol 2005; 23:8165-8169. (Pubitemid 46211550)
6. Carter HB, Kettermann A, Warlick C, et al. Expectantmanagementofprostate cancerwith curative intent: an update of the Johns Hopkinsexperience. J Urol 2007; 178:2359-2364.
7. Dall'Era MA, Konety BR, Cowan JE, et al. Active surveillance for the manage-mentofprostatecancer in acontemporarycohort. Cancer 2008; 112:2664-2670.
8. Onik G, Narayan P, Vaughan D, et al. Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002; 60:109-114. (Pubitemid 34722957)
9. Bahn DK, Silverman P, Lee F Sr, et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 2006; 20:688-692. (Pubitemid 46140997)
10. Muto S, Yoshii T, Saito K, et al. Focal therapy with high-intensity- focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008; 38:192-199. (Pubitemid 351419743)
11. Bostwick DG, Waters DJ, Farley ER, et al. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.
12. Eggener SE, Scardino PT, Carroll PR, et al., International Task Force on Prostate Cancer and the Focal Lesion Paradigm. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178:2260-2267. (Pubitemid 350052204)
13. Tareen B, Godoy G, Sankin A, et al. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 2009; 104:195-199.
14. Falzarano SM, Zhou M, Hernandez AV, et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology 2010; 76:682-687.
15. Crawford ED, Wilson SS, Torkko KC, et al. Clinical staging ofprostatecancer: a computer-simulated study of transperineal prostate biopsy. BJU Int 2005; 96:999-1004. (Pubitemid 41531402)
16. Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic map-ping oftheprostate: a 4-year experience. Urology 2007; 70 (6 Suppl):27-35.
17. Onik G, Miessau M, Bostwick DG. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol 2009; 27:4321-4326.
18. Taira AV, Merrick GS, Galbreath RW, et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 2010; 13:71-77.
19. Stamey TA, Freiha FS, McNeal JE, et al. Localized prostate cancer. Relation-ship of tumorvolume to clinical significance fortreatment of prostate cancer. Cancer 1993; 71 (3 Suppl):933-938. (Pubitemid 23049614)
20. Villers A, Puech P, Mouton D, et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006; 176:2432-2437. (Pubitemid 44665992)
21. Ahmed HU, Kirkham A, Arya M, et al. Is ittime toconsidera rolefor MRI before prostate biopsy? Nat Rev Clin Oncol 2009; 6:197-206.
22. Toi A, Neill MG, Lockwood GA, et al.The continuing importanceof transrectal ultrasound identification of prostatic lesions. J Urol 2007; 177:516-520. (Pubitemid 46054011)
23. Eisenberg ML, Cowan JE, Davies BJ, et al.The importanceoftumorpalpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol 2009 (in press)
24. Trabulsi EJ, Sackett D, Gomella LG, Halpern EJ. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology 2010; 76:1025-1033.
25. Ukimura O. Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer. Expert Rev Med Devices 2010; 7:541-554.
26. Andriole GL, Bullock TL, Belani JS, et al. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology 2007; 70 (6 Suppl):22-26.
27. Megwalu II, Ferguson GG, Wei JT, et al. Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer. BJU Int 2008; 102:546-550.
28. Andriole GL. Pathology: the lottery of conventional prostate biopsy. Nat Rev Urol 2009; 6:188-189.
29. Guo Y, Werahera PN, Narayanan R, et al. Image registration accuracy of a 3-dimensional transrectal ultrasound-guided prostate biopsy system. J Ultrasound Med 2009; 28:1561-1568.
30. Shen F, Narayanan R, Suri JS. Rapid motion compensation for prostate biopsy using GPU. Conf Proc IEEE Eng Med Biol Soc 2008; 2008:3257-3260.
31. Karnik VV, Fenster A, Bax J, et al. Assessment of image registration accuracy in three-dimensional transrectal ultrasound guided prostate biopsy. Med Phys 2010; 37:802-813.
32. Cool DW, Gardi L, Romagnoli C, et al. Temporal-based needle segmentation algorithm for transrectal ultrasound prostate biopsy procedures. Med Phys 2010; 37:1660-1673.
33. Babaian RJ, Donnelly B, Bahn D, et al. Best practice statement on cryo surgery for the treatment of localized prostate cancer.J Urol 2008; 180:1993-2004.
34. Uchida T, Shoji S, Nakano M, et al. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experi-ence. Int J Urol 2009; 16:881-886.
35. Crouzet S, Rebillard X, Chevallier D, et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 pa-tients. Eur Urol 2010; 58:559-566.
36. Baumann M, Mozer P, Daanen V, Troccaz J. Prostate biopsy assistance systemwith gland deformation estimationforenhanced precision. Med Image Comput Comput Assist Interv 2009; 12 (Pt 1):67-74.
37. Mozer P, Baumann M, Chevreau G, et al. Mapping of transrectal ultrasono-graphic prostate biopsies: quality control and learning curve assessment by image processing. J Ultrasound Med 2009; 28:455-460.
38. Puech P, Potiron E, Lemaitre L, et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology 2009; 74: 1094-1099.
39. Fradet V, Kurhanewicz J, Cowan JE, et al. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology 2010; 256:176-183.
40. De Visschere PJ, De Meerleer GO, Fütterer JJ, Villeirs GM. Role of MRI in follow-up after focal therapy for prostate carcinoma. AJR Am J Roentgenol 2010; 194:1427-1433.
41. Stoianovici D, Song D, Petrisor D, et al. MRI Stealth robot for prostate interventions. Minim Invasive Ther Allied Technol 2007; 16:241-248. (Pubitemid 47343471)
42. Yakar D, Hambrock T, Huisman H, et al. Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy. Invest Radiol 2010; 45:121-125.
43. Tokuda J, Fischer GS, DiMaio SP, et al. Integrated navigation and control software system for MRI-guided robotic prostate interventions. Comput Med Imaging Graph 2010; 34:3-8.
44. Kaplan I, Oldenburg NE, Meskell P, et al. Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging 2002; 20:295-299. (Pubitemid 34791371)
45. Singh AK, Kruecker J, Xu S, et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided pros-tate biopsy. BJU Int 2008; 101:841-845. (Pubitemid 351347719)
46. Turkbey B, Xu S, Kruecker J, et al. Documenting the location of prostate biopsies with image fusion. BJU Int (in press)
47. Ukimura O, Hirahara N, Fujihara A, et al. Technique for a hybrid system of real-time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy. Int J Urol 2010; 1 7: 890-893.
48. Hu Y, Ahmed H, Allen C, et al. MRto ultrasound image registrationforguiding prostate biopsy and interventions. MICCAI 2009; 1:787-794.
49. Ukimura O, Gill IS. Image-fusion, augmented reality, and predictive navigation. Urol Clin North Am 2009; 36:115-123.
50. Ho HS, Mohan P, Lim ED, et al. Robotic ultrasound-guided prostate inter-vention device: system description and results from phantom studies. Int J Med Robot 2009; 5:51-58.